Barclays Reiterates Overweight Rating on Oracle
- Rating
- Buy
- Price target
- $240
- Implied upside
- +12%
- vs $213.68 prior close

Barclays analyst Raimo Lenschow reiterated an Overweight rating and $240.00 price target on Oracle (NYSE: ORCL).
“Q4 should see another AI-driven acceleration that helps reinforce the LT growth story.
However, it does seem AI sentiment is at a ST crossroad with some examples of DC delays (industry-wide, not ORCL specific) and inflation, which creates questions around CapEx & guidance for ORCL and its new CFO.
We Continue to Like the LT ORCL Growth Story and Reiterate our OW Rating: We maintain our price target of $240 based on ~25x our CY27E adj. EPS estimate of $9.46.
We continue to see a compelling risk/reward for Oracle shares at current levels when considering expectations for ORCL to soon be at 30%+ total revenue growth and continue to view Oracle’s full stack (IaaS/ PaaS/SaaS) offering, enterprise data gravity and cloud database migration story as key differentiators supporting its long-term value proposition.
We maintain our Overweight rating.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Tracking this call
Since this note−32% ORCL $213.68 → $144.77 (Oct 7) · moving away from the target
This callScored on Dec 8, 2026, six months after the note: did ORCL reach $240?
Firm track recordBarclays reached 80% of its 40 scored targets within six months (#4 of 31 firms); on Oracle, 2 of 3. Accuracy ranking →





